45
Participants
Start Date
June 11, 2025
Primary Completion Date
August 1, 2026
Study Completion Date
November 1, 2026
Prism
Prism is using an amygdala-fMRI-guided model for processing EEG signals. The model, termed EEG fMRI pattern (EFP), uses several electrodes EEG-signal to produce a real time amygdala-EFP biomarker signal. GrayMatters' product, Prism, is used to train patients in downregulating the amygdala-derived-EFP biomarker during therapy sessions.
RECRUITING
NYU Langone Health, New York
GrayMatters Health Ltd.
INDUSTRY